Indeed, IL1RAP knockdown in primary AML cells is accompanied by a reduction in clonogenicity, and BM cells from IL1RAP knockout (IL1RAP-/-) mice transduced with MLL-AF9 fusion viruses show slower disease progression than recipients of wild type cells transduced with the same onco-vector [54]. This evidence concerns the gene KMT2A and acute myeloid leukemia.